Peter Ghali

Immune Modulating and Immunosuppressive Drugs

Barrett Attarha, Radhika Sharma, Vinit H. Majmudar, Lee Shapiro et autres

us (code pays fourni par la source)

Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: A Population-Based Epidemiological Study

Atefeh Vaezi, Tracy Ashby, Michael Schweitzer, Peter Ghali et autres

INTRODUCTION: We aim to investigate the contribution of interstitial lung disease (ILD) to mortality in patients with inflammatory bowel disease (IBD). METHODS: We performed a comprehensive retrospective, population-based epidemiological study across the United States from 2001 to 2020, using the Wide-ranging Online …

us (code pays fourni par la source)

FIZZ AND FECALOMA: THE USE OF ILEOSTOMY ENEMAS AND CARBONATED SODA INJECTIONS IN A PATIENT WITH PERSISTENT RESIDUAL STOOL BURDEN

Gerardo Diaz Garcia, Luke Stachler, Gregory Churchill, Barrett Attarha et autres

Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: An Epidemiologic Analysis

Atefeh Vaezi, Peter Ghali, Mehdi Mirsaeidi

us (code pays fourni par la source)

Kidney after liver transplantation does not have an increased risk of rejection compared to liver alone

Peter Ghali, Ramez Ibrahim, David O. Hodge, Launia J. White et autres

BACKGROUND: Simultaneous liver kidney (SLK) transplant protects against acute cellular rejection. In 2017, UNOS implemented a "safety net" policy to allow patients with renal recovery to avoid renal transplantation. Whether kidney after liver transplantation (KALT) increases the risk of rejection is unknown. …

us (code pays fourni par la source)

Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy

Rose Mary Attieh, Ramez Ibrahim, Peter Ghali, Andrew P. Keaveny et autres

The number of kidney after liver transplants (KALT) increased after the implementation of the United Network of Organ Sharing (UNOS) safety net policy, but the effects of the policy on KALT outcomes remain unknown. Using the UNOS database, we identified KALT between …

us (code pays fourni par la source)

Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey

Karthik Gnanapandithan, Peter Ghali

Hepatitis C virus (HCV) is a global health issue with an estimated prevalence of 2.4 to 3 million people in the US and 58 million worldwide. Previous reports from the US have shown that close to half of those with the infection …

us (code pays fourni par la source)

Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography

Andre Fialho, Andrea Fialho, Bruno Ribeiro, Miguel Malespin et autres

Background A possible association between Helicobacter pylori (HP) infection and liver diseases including steatosis is suspected. There is a lack of studies evaluating the association of HP and liver steatosis severity using transient elastography. Aim The aim of this study was to …

us (code pays fourni par la source)

Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study

Alshaima Alhinai, Afsheen Qayyum-Khan, Xun Zhang, Patrick Samaha et autres

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) seem common after liver transplantation. AIM: To investigate incidence and predictors of NAFLD and NASH by employing noninvasive testing in liver transplant recipients, namely controlled attenuation parameter (CAP) and the serum biomarker …

ca, us (code pays fourni par la source)

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)

Giada Sebastiani, Keyur Patel, Vlad Ratziu, Jordan J. Feld et autres

Non-alcoholic fatty liver disease (NAFLD) affects approximately 8 million Canadians. NAFLD refers to a disease spectrum ranging from bland steatosis to non-alcoholic steatohepatitis (NASH). Nearly 25% of patients with NAFLD develop NASH, which can progress to liver cirrhosis and related end-stage complications. …

ca, fr, us, gb, it, ch (code pays fourni par la source)

Hepatorenal syndrome: pathophysiology and evidence-based management update

Irtiza Hasan, Tasnuva Rashid, Răzvan M. Chirilă, Peter Ghali et autres

Hepatorenal syndrome (HRS) is a functional renal failure that develops in patients with advanced hepatic cirrhosis with ascites and in those with fulminant hepatic failure. The prevalence of HRS varies among studies but in general it is the third most common cause …

us (code pays fourni par la source)

Pretransplant Use of the Chronic Kidney Disease Epidemiology Collaboration Equation (CKD-EPI) to Estimate Glomerular Filtration Rate Predicts Outcomes in Liver Transplant Recipients

Ahmed AlQallaf, Ahsan Alam, Ruth Sapir‐Pichhadze, Peter Ghali et autres

OBJECTIVES: Kidney dysfunction is common in liver transplant candidates and is a well-established predictor of increased mortality after liver transplant. However, the best method for determination of the glomerular filtration rate before liver transplant remains unclear. MATERIALS AND METHODS: We analyzed the …

ca (code pays fourni par la source)